Form 4 for IRMD IRADIMED CORP
Accepted 2024-12-02 00:00:00 ET · period of report 2024-12-02 · accession 0001415889-24-028036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-02 | 2024-12-02 | IRMD | GLENN JOHN | CFO | S - Sale | $54.18 | -2,500 | 4,383 | -36% | -$135.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | S | D | 2,500 | $54.18 | 4,383 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $54.00 to $54.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |